We report whole-genome sequences (WGSs) for four varicella-zoster virus (VZV) samples from a shingles study conducted by Kaiser Permanente of Southern California. Comparative genomics and phylogenetic analysis of all published VZV WGSs revealed that strain KY037798 is in clade IX, which shall henceforth be designated clade 9. Previously published single nucleotide polymorphisms (SNP)-based genotyping schemes fail to discriminate between clades 6 and VIII and employ positions that are not clade-specific. We provide an updated list of clade-specific positions that supersedes the list determined at the 2008 VZV nomenclature meeting. Finally, we propose a new targeted genotyping scheme that will discriminate the circulating VZV clades with at least a twofold redundancy. Genotyping strategies using a limited set of targeted SNPs will continue to provide an efficient 'first pass' method for VZV strain surveillance as vaccination programmes for varicella and zoster influence the dynamics of VZV transmission.
INTRODUCTION
Varicella-zoster virus (VZV) is a human alphaherpesvirus that causes a febrile, generalized pruritic rash illness called varicella (chickenpox) on primary infection; the virus establishes a lifelong latent infection in the dorsal root ganglia. Varicella usually runs a mild course, but can be complicated by encephalitis, pneumonia, disseminated disease and group A streptococcal superinfection [1] . The virus can reactivate from latency to cause a painful, dermatomally distributed rash illness called herpes zoster (HZ), or shingles. About a third of HZ patients >60 years of age develop post-herpetic neuralgia (PHN), in which localized pain can persist for months to years after the rash resolves [2] .
The VZV genome is double-stranded DNA averaging 125 000 base pairs in length, comprising at least 72 open reading frames (ORFs). Sixty-three ORFs are located in the unique long region (U L ), followed by the three open reading frames as well as the origin of replication that are encoded in the internal repeat short (IRs) and repeated in the terminal repeat short (TRs). The IRs and the TRs together flank the unique short region (US), which encodes four ORFs. Five small regions, each comprising variable numbers of short direct sequence repeats (reiteration regions) are also present in the genome (R1-R5). Three of these -R1, R2 and R3 -are located within the coding region of genes. The R4 region is in the IRs and is duplicated in the TRs [1] (Fig. S1 , available in the online Supplementary Material).
VZV nomenclature currently recognizes nine clades, six established clades designated by Arabic numerals 1 to 6, and three provisional clades designated by the Roman numerals VII, VIII and IX [3, 4] . In accordance with the nomenclature system proposed in 2008, two WGSs are needed to redesignate a provisional clade as established. The advent of next-generation sequencing (NGS) technology has led to the publication of numerous VZV WGSs, which has in turn resulted in the redesignation of clade VI as established clade 6 [5] . Most clinical samples of VZV are non-viable, a problem that previously curtailed the extent of sequencing that was feasible on small amounts of viral DNA. Prior to the availability of high-throughput NGS, genotyping strategies relied on targeted sequencing of informative SNPs. Several groups published methods for identifying VZV clades using targeted SNP analysis that were useful for discriminating the seven clades recognized at that time [3, 6] . Those methods are now unsuitable for the reliable discrimination of the currently recognized VZV clades. Genotyping methods based on determining targeted SNP are still useful as a means for conducting strain surveillance, as well as for the identification of isolates of interest for more detailed follow-up. We propose here a new SNP-based VZV genotyping scheme that can reliably discriminate all recognized VZV clades.
RESULTS
Phylogenetic analysis showed that one of the WGSs reported here (KY037798) is closely related to the clade IX representative (JN704710), and therefore fulfils the requirement to designate this as an established genotype, clade 9 ( Fig. 1) . Indeed, based on publicly available data, an additional published VZV sequence for clade 9 is now available, as the previously reported KP771890 clusters with KY037798 and JN704710.
The comparative genomics of all published WGSs shows that the previous genotyping schemes, including the scheme we published in 2007 [6] , are no longer appropriate (Table 1a) , The less common discriminating SNP are highlighted in black. The genomic positions, 38 081A and 38 177G, are not clade-specific, as previously reported, as they are only found in one of the three clade 9 genomes (JN704710). Also, our previous genotyping scheme does not differentiate between clade 6 and clade VIII. Many of the SNP positions identified as clade-specific in the 2008 VZV nomenclature meeting have no or limited usefulness today. Consequently, a new genotyping scheme is necessary. Two hundred and seventeen SNPs specific to individual VZV clades are listed in Table S2 . Seven positions have been selected, three of which were included in our original genotyping scheme (Table 1b) . The revised strategy provides redundancy in the number of confirmatory SNPs for each VZV clade, enhancing its robustness. Only one clade VII sample has been identified, and sequencing was limited to only four SNPs in ORF22. It is not possible to definitively genotype clade VII using this revised genotyping scheme. Since more than 3000 globally distributed samples have now been genotyped without identifying a second clade VII virus, these viruses may no longer be actively circulating. Clade VIII and clade 6 are more closely related than any other pair of VZV clades. Only 42 positions can differentiate the genomes from these two clades compared with about 150 nucleotides that differentiate all other clade pairings. It is debatable whether clades 6 and VIII actually represent subvariants of the same VZV clade.
Among the four new WGSs reported here, KP702725 (clade 6) features an unusual genomic organization. This includes a smaller Us region (5185 nt), which is otherwise well conserved among VZV genomes (5233 nt +/-0.31) ( Table S3 ). The genomic structure is schematically represented in Fig. S2 . The 48 nucleotides normally found at the 3¢ terminus of the US region are included in TRs; these are duplicated and inverted, and located at the 3¢ terminus of IR S (Fig. S2, shown in green) . Furthermore, these repeated nucleotides include a methionine codon that could result in the expression of the last 44 amino acid residues of the carboxy-terminus of ORF68 (Fig. S2 , shown in red), but no associated promoter region was identified. Lastly, 98 bases usually found at the 3¢ terminus of IR S are duplicated at the end of IR S (Fig. S2, shown in pink) . New primers designed to create an independent PCR reaction on the original DNA yielded an amplicon with identical sequence, demonstrating that this unusual genome organization was not an experimental artefact (data not shown). As with all of the VZV samples obtained during the course of the Kaiser Permanente Herpes Zoster Study, KP702725 was non-viable, precluding phenotypic characterization of the strain. Strain KP702725 was obtained from a case of HZ in an 88-yearold who had resided in the USA for >25 years and developed varicella. The clinical features of HZ in this patient were unremarkable.
The clade 2 and clade 5 isolates were selected because published complete genome sequences are underrepresented for those genotypes. The clade 2 sample (KY037796)
was from the sub-variant that does not share the Oka vaccine-associated profile of parental Oka. There were no unusual features in this clade 2 strain. The clade 5 sample (KY037797) contained the same vaccine-specific SNP at ORF62 position 107252 (reference sequence: Dumas strain, accession #NC001348) [7] .
DISCUSSION
Increasingly, VZV genomes are being sequenced using NGS technology. Although NGS provides an efficient means to sequence the unique portions of the VZV genome, currently available platforms do not reliably sequence some of the reiteration regions due to their size and highly repetitive sequence. These regions are potentially important as they are variably sized, with three occurring within the reading frames of important VZV genes and two being proximal to the origins of replication. More than 1300 WGS have recently been generated using NGS. While these sequences include most of the viral information (all of the ORFs), they cannot be used to accurately compute basic genomic information, e.g. genome length, GC content and genomic structure (IRs/TRs, R1-R5).
We have explored using NGS platforms that can process longer DNA fragments, thus far with unsatisfactory results. Currently, only Sanger technology generates reliable sequences through the longer reiteration regions of the genome, and it is required to independently sequence the two separate copies of 
R4 in the IRs and TRs. In the absence of new advances, a combination of Sanger and NGS technologies will increase both the efficiency (more genomic sequences) and the completeness of VZV genomic sequencing. As illustrated by our KP702725 clade 6 sample, the VZV genome structure can feature some abnormalities that might not be identified using NGS technologies, which are primarily based on comparison with a reference genome.
Only a single, fully sequenced clade 9 isolate (JN704710) had been previously identified and described in the literature [4] . The complete genome sequence for the KPSC study isolate (KY037798) identified in this study fulfilled the requirement for redesignating provisional clade IX as established clade 9. In addition, analysis of the complete sequences published on GenBank revealed a partial genome sequence (excluding the R regions) for a third clade 9 isolate, KP771890 [5] .
NGS is useful, but is not required for the identification of VZV clades. Using targeted SNP analysis will become important as varicella and zoster incidence rates decrease in countries with broad vaccination policies, which will likely shift VZV clade distribution. This was observed for other viruses with widespread vaccination programmes, e.g. measles [8] . Genotyping large numbers of clinical samples with a targeted SNP approach is more practical than NGS for surveillance purposes. Identifying and cataloguing clade-specific SNPs at regular intervals will be needed to update genotyping strategies as new clades are identified and the database for VZV sequences expands. For example, positions 38 081 and 38 177 were previously identified as specific for clade 9, but new sequences show that these positions are not clade 9-specific. Whereas the previous genotyping scheme required the interrogation of seven genomic positions in three amplicons, our proposed genotyping scheme requires six amplicons and also scans seven positions. Although the new genotyping scheme is more labour-intensive, it unambiguously discriminates all VZV clades except clade VII (no complete genome sequence is available) and covers a broader expanse of the genome, which will likely make it a useful preliminary tool for identifying recombinant viruses. Specifically, if the distribution of SNPs identifies a pattern inconsistent with the established clades, whole-genome sequencing would be required for evaluation as a possible recombinant strain. Evidence for recombination between VZV clades was recently reported [5] and could lead to further refinements of VZV isolate classification.
METHODS
The four WGSs determined for this report were derived using a long PCR amplicon-based strategy, which has been described previously [9] . Briefly, 17 overlapping amplicons were sequenced using conventional Sanger sequencing (Fig.  S1 ). The DNA was extracted from skin lesion swabs and the template quality played a major role in the robustness of the PCR amplification. Some amplicons required the preparation of more than one PCR reaction to sequence the entire stretch of DNA. Sometimes alternate primer pairs or second-round amplification were required. A manuscript is in preparation that will describe both the detailed long PCR method and the more than 700 primers used to sequence the amplicons. The genome termini were determined by circularizing the genome and amplifying a 2 kb fragment across the ligated ends. Sequences were assembled using Sequencher version 5.2.3 (Gene Codes Corp., Ann Arbor, MI, USA). The number of sequences used in the assembly, as well as the coverage for the four WGSs reported in this paper, are indicated in Table S1 . The WGSs were annotated with Artemis software [10] using Dumas strain (NC001348) as a template. All 102 publicly available VZV WGSs (or nearly complete genomic sequences) were downloaded from GenBank (search 10 May 2016). The WGSs were analysed using the analysis scheme developed by Zell and coworkers [4] , specifically, limiting analyses to unique sequences. The genome sequence was divided into eight distinct regions (A to H), as illustrated in Fig. S1 . Sequences for each region were aligned with MUSCLE [11] or MAFFT [12] . Alignment was analysed in BioEdit (www.mbio.ncsu.edu/BioEdit/bioedit.html). The SNPs were listed in MEGA 6 [13] .
The phylogenetic tree of the concatenated SNPs throughout the whole genome was generated in MEGA6 with the neighbour-joining method and a maximum composite likelihood nucleotide substitution model [14, 15] .
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